Spotlight -

Long-Acting Injectable Therapy in the Management of Adult Patients with Schizophrenia|

Major Depressive Disorder

Kazunari Yoshida, MD, PhD

Articles by Kazunari Yoshida, MD, PhD

Using Pharmacogenetics in Making Treatment Decisions for Schizophrenia

ByKazunari Yoshida, MD, PhD,Daniel J. Müller, MD, PhD

March 29th 2019

Latest Updated Articles

Using Pharmacogenetics in Making Treatment Decisions for Schizophrenia
March 29th 2019

Trending on Psychiatric Times

Centanafadine For Comorbid ADHD and Anxiety: Talking New Data With John Kraus, MD, PhD

New Real-World Data Supporting Cariprazine for MDD and Bipolar I Depression

Brenipatide for Alcohol Use Disorder: Emerging Findings

Pimavanserin Linked to Fewer Falls Than Other Antipsychotics in Parkinson Disease Psychosis

The Silence Between the Questions: Reflections on Adolescent Suicide Risk When Intent Is Unclear